Discovery & Innovation

This blog post was written by Kevin Lustig, Cofounder and CEO of Scientist.com. For many large CROs and CDMOs, the rise of research orchestration...

This blog post was written by Kevin Lustig, Cofounder and CEO of Scientist.com and Chris Petersen, Cofounder and CTO of Scientist.com. For years...

Over the course of this series, we have examined how supply chain fragmentation, complexity, predictive models, and distributed partnerships are...

This blog post was written by BrainXell. An industry-leading producer of neurons and glia advancing neuroscience research and partnering with over...

In the first three installments of this series, we explored the shifts redefining pharmaceutical development and manufacturing (PharmDev): supply...

In the first two installments of this series, we explored 2 major reasons why pharmaceutical development and manufacturing (PharmDev) is being...

In the first installment of this series, we explored the Resilience Pivot — why pharmaceutical development and manufacturing (PharmDev) is moving...

As we kick off 2026, the era of predictable, cost-optimized manufacturing has largely been replaced by one of geopolitical shifts...

In a recent article that appeared in the San Diego Union Tribune, Matt McLoughlin, Senior VP Compliance and Category Management at Scientist.com...

This blog post was written by Applied Pathology Systems (APS). Based in Massachusetts, Applied Pathology Systems (APS) is a premier...